Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nesrina Imami

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|January 27, 2007
Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccineMark Page, Agatha Ojugo, Nesrina Imami, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2019
Pregnancy-related immune suppression leads to altered influenza vaccine recall responsesNishel M Shah, Nesrina Imami, Peter Kelleher, et al.
Antiviral Therapy|March 26, 2004
Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapyAntonio Pires, Jeffrey Pido-Lopez, Graeme Moyle, et al.
AIDS (London, England)|August 4, 2011
T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsivenessJocelyn S Downey, Meriem Attaf, Graeme Moyle, et al.
Molecular Medicine (Cambridge, Mass.)|August 10, 2012
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infectionSamantha J Westrop, Graeme Moyle, Akil Jackson, et al.
The Journal of Infectious Diseases|April 30, 2004
Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individualsAnthony Kebba, Pontiano Kaleebu, Samantha Rowland, et al.
Journal of Immune Based Therapies and Vaccines|November 4, 2008
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-upAnna A Herasimtschuk, Samantha J Westrop, Graeme J Moyle, et al.
Plos One|February 25, 2012
Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010Sundhiya Mandalia, Samantha J Westrop, Eduard J Beck, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Immune reconstitution in HIV-1-infected patientsNesrina Imami, Gareth Hardy, Antonio Pires, et al.
AIDS Research and Human Retroviruses|January 3, 2019
Short Communication: Therapeutic Immunization Benefits Mucosal-Associated Invariant T Cell Recovery in Contrast to Interleukin-2, Granulocyte-Macrophage Colony-Stimulating Factor, and Recombinant Human Growth Hormone Addition in HIV-1+ Treated Patients: Individual Case Reports from Phase I TrialAlexander T H Cocker, Louise Greathead, Anna A Herasimtschuk, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|January 27, 2007
Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccineMark Page, Agatha Ojugo, Nesrina Imami, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2019
Pregnancy-related immune suppression leads to altered influenza vaccine recall responsesNishel M Shah, Nesrina Imami, Peter Kelleher, et al.
Antiviral Therapy|March 26, 2004
Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapyAntonio Pires, Jeffrey Pido-Lopez, Graeme Moyle, et al.
AIDS (London, England)|August 4, 2011
T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsivenessJocelyn S Downey, Meriem Attaf, Graeme Moyle, et al.
Molecular Medicine (Cambridge, Mass.)|August 10, 2012
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infectionSamantha J Westrop, Graeme Moyle, Akil Jackson, et al.
The Journal of Infectious Diseases|April 30, 2004
Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individualsAnthony Kebba, Pontiano Kaleebu, Samantha Rowland, et al.
Journal of Immune Based Therapies and Vaccines|November 4, 2008
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-upAnna A Herasimtschuk, Samantha J Westrop, Graeme J Moyle, et al.
Plos One|February 25, 2012
Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010Sundhiya Mandalia, Samantha J Westrop, Eduard J Beck, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Immune reconstitution in HIV-1-infected patientsNesrina Imami, Gareth Hardy, Antonio Pires, et al.
AIDS Research and Human Retroviruses|January 3, 2019
Short Communication: Therapeutic Immunization Benefits Mucosal-Associated Invariant T Cell Recovery in Contrast to Interleukin-2, Granulocyte-Macrophage Colony-Stimulating Factor, and Recombinant Human Growth Hormone Addition in HIV-1+ Treated Patients: Individual Case Reports from Phase I TrialAlexander T H Cocker, Louise Greathead, Anna A Herasimtschuk, et al.
Pageof 6